AVCT Avacta Group PLC LSE · United Kingdom

Avacta Group (AVCT) news

Avacta Group PLC is a public biotech or pharmaceutical company listed on LSE under the ticker AVCT, recorded under United Kingdom. The directory classifies it as Oncology drug developer. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Avacta Group news

We have not published a story on Avacta Group yet. When there is news, it will appear here.

Questions about Avacta Group

What is the ticker symbol of Avacta Group?

Avacta Group PLC trades under the ticker AVCT on LSE.

Where is Avacta Group listed?

Avacta Group PLC is listed on LSE.

Which country or territory is Avacta Group listed under?

Our directory records Avacta Group PLC under United Kingdom.

What does Avacta Group do?

Our directory classifies Avacta Group PLC as: Oncology drug developer. This is a directory classification, not a description of the pipeline.

What is the ISIN of Avacta Group?

The ISIN recorded for Avacta Group PLC is GB00BYYW9G87.

Does aibio.space cover Avacta Group?

aibio.space lists Avacta Group PLC among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Avacta Group?

Companies in our directory listed in the same country and business area as Avacta Group: Haleon, Bicycle Therapeutics, Solvonis Therapeutics Plc, Roivant Sciences, AstraZeneca, Biodexa Pharmaceuticals.

Investor discussion: Avacta Group

Members talk about Avacta Group (AVCT). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open LSE:AVCT on TradingView.

Listing details

Company: Avacta Group PLC
Ticker: AVCT
Listing: LSE
Country or territory: United Kingdom
Business scope: Oncology drug developer
ISIN: GB00BYYW9G87
Last quote in directory: 2026-10-22
Directory source: Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction